Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension of phase 3 duloxetine trial in osteoarthritis
jRCT2080222774Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of duloxetine in knee osteoarthritis (OA) and osteoarthritis (OA) (2 arms), sponsored by Shionogi & Co., Ltd.
02
Drugs
duloxetine
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2080222774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222774.